Mucosal biomarkers of colorectal cancer risk do not increase at 6 months following sleeve gastrectomy, unlike gastric bypass

Obesity

Volumn 22, Issue 1, 2014, Pages 202-210

  Kant, Prashant ^a   Perry, Sarah L ^a   Dexter, Simon P ^a   Race, Amanda D ^b   Loadman, Paul M ^b   Hull, Mark A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MESSENGER RNA; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; APOPTOSIS; ARTICLE; BODY MASS; CANCER RISK; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; COX 1 GENE; COX 2 GENE; EVIDENCE BASED MEDICINE; FEMALE; GAPDH GENE; GENE; GENE EXPRESSION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IL 1BETA GENE; IL 6 GENE; INFLAMMATION; INTERMETHOD COMPARISON; INTESTINE CRYPT; INTESTINE EPITHELIUM CELL; MALE; MIF GENE; MITOSIS; MONONUCLEAR CELL; MORBID OBESITY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECTUM MUCOSA; SLEEVE GASTRECTOMY; STOMACH BYPASS; SURGICAL TECHNIQUE; TISSUE DISTRIBUTION; TNFALPHA GENE; UPREGULATION; WEIGHT REDUCTION;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; GASTRECTOMY; GASTRIC BYPASS; HUMANS; INFLAMMATION; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; OBESITY, MORBID; RNA, MESSENGER; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS; YOUNG ADULT;

EID: 84892365599     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20493     Document Type: Article

References (22)

1. Eldar S, Heneghan HM, Brethauer SA, Schauer PR,. Bariatric surgery for treatment of obesity. Int J Obes 2011; 35: S16-S21.
2. Burns EM, Naseem H, Bottle A, et al. Introduction of laparoscopic bariatric surgery in England: Observational population cohort study. Br Med J 2010; 341: c4296.
3. Brethauer SA, Hammel JP, Schauer PR,. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis 2009; 5: 469-475.
4. Kant P, Hull MA., Excess body weight and obesity-the link with gastrointestinal and hepatobiliary cancer. Nature Rev Gastroenterol Hepatol 2011; 8: 224-238.
5. Sjöström L, Gummesson A, Sjöström CD, et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): A prospective, controlled intervention trial. Lancet Oncol 2009; 10: 653-662.
6. Adams TD, Stroup AM, Gress RE, et al. Cancer incidence and mortality after gastric bypass surgery. Obesity 2009; 17: 796-802.
7. Christou NV, Lieberman M, Sampalis F, Sampalis JS,. Bariatric surgery reduces cancer risk in morbidly obese patients. Surg Obes Rel Dis 2008; 4: 691-695.
8. Derogar M, Hull MA, Kant P, Ostlund M, Lu Y, Lagergren J,. Increased risk of colorectal cancer after obesity surgery in a retrospective cohort study. Ann Surg 2013; DOI: 10.1097/SLA.0b013e318288463a.
9. Sainsbury A, Goodlad RA, Perry SL, Pollard SG, Robins GG, Hull MA,. Increased colorectal epithelial cell proliferation and crypt fission associated with obesity and Roux-en-Y gastric bypass. Cancer Epidemiol Biomarkers Prev 2008; 17: 1401-1410.
10. Kant P, Sainsbury A, Reed KR, et al. Rectal epithelial cell mitosis and expression of macrophage migration inhibitory factor are increased three years after Roux-en-Y gastric bypass (RYGB) for morbid obesity: Implications for long-term neoplastic risk following RYGB. Gut 2011; 60: 893-901.
11. Nakatani H, Kasama K, Oshiro T, Watanabe M, Hirose H, Itoh H,. Serum bile acid along with plasma incretins and serum high-molecular weight adiponectin levels are increased after bariatric surgery. Metabolism 2009; 58: 1400-1407.
12. Pournaras DJ, Glicksman C, Vincent RP, et al. The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology 2012; 153: 3613-3619.
13. Zhang H, DiBaise JK, Zuccolo A, et al,. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci USA 2009; 106: 2365-2370.
14. Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences microbial-host metabolic cross-talk. Gut 2011; 60: 1214-1223.
15. 2 synthesis in healthy humans and those with lung cancer. Anal Biochem 2004; 334: 266-275.
16. Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg 2005; 15: 1024-1029.
17. Benedix F, Westphal S, Patschke R, et al. Weight loss and changes in salivary ghrelin and adiponectin: Comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding. Obes Surg 2011; 21: 616-624.
18. Ghanim H, Aljada A, Hofmeyer D, Syed T, Mohanty P, Dandona P,. Circulating mononuclear cells in the obese are in a proinflammatory state. Circulation 2004; 110: 1564-1571.
19. Sheu WH-H, Chang T-M, Lee W-J, et al. Effect of weight loss on proinflammatory state of mononuclear cells in obese women. Obesity 2008; 16: 1033-1038.
20. Goyenechea E, Parra D, Crujeiras AB, Abete I, Martinez JA,. An inflammation-related approach to predict the weight-loss regain in obese subjects. Ann Nutr Metab 2009; 54: 43-51.
21. 2 metabolite and risk for colorectal adenoma. Cancer Prev Res 2011; 5: 336-342.
22. Wu X, Cai H, Xiang Y-B, et al. Intra-person variation of urinary biomarkers of oxidative stress and inflammation. Cancer Epidemiol Biomarkers Prev 2010; 19: 947-952.